Ryan Preblick - 09 Feb 2026 Form 4 Insider Report for Indivior Pharmaceuticals, Inc. (INDV)

Signature
/s/Alice Givens, Power of Attorney
Issuer symbol
INDV
Transactions as of
09 Feb 2026
Net transactions value
$0
Form type
4
Filing time
12 Feb 2026, 16:07:23 UTC
Previous filing
07 Jan 2026
Next filing
05 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Preblick Ryan Chief Financial Officer 10710 MIDLOTHIAN TURNPIKE, SUITE 125, NORTH CHESTERFIELD /s/Alice Givens, Power of Attorney 12 Feb 2026 0002014866

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INDV Common Stock Award $0 +37,358 +13% $0.000000 317,940 10 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDV Performance Stock Units Award $0 +113,510 $0.000000 113,510 09 Feb 2026 Common Stock 113,510 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer.
F2 On March 3, 2023, the Reporting Person was granted a conditional award for 113,510 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026. The shares will then be subject to an additional two-year Holding Period before the vested Shares are released to the Reporting Person.

Remarks:

Exhibit 24 Power of Attorney